Algernon Launching Research Program For

May 22, 2026
Quick Overview: CEO Chris Moreau discusses the recent Ifendprodil transaction with Seyltx and plans and milestones for This video features Joni Rutter, PhD, Director of Scientific Programs for the All of Us

Algernon Launching Research Program For - Detailed Overview & Context

CEO Chris Moreau discusses the recent Ifendprodil transaction with Seyltx and plans and milestones for This video features Joni Rutter, PhD, Director of Scientific Programs for the All of Us

Photo Gallery

Algernon launching research program for treatment of stroke using Psychedelic drug DMT
Algernon Pharmaceuticals launches new chronic kidney disease research program using Repirinast
Algernon Pharmaceutical’s DMT Clinical Research Program for Stroke receives positive FDA feedback
Algernon Pharmaceuticals provides update on chronic kidney disease research program with NP-251
Algernon Pharmaceuticals Stroke/DMT Clinical Program
Algernon Pharmaceuticals plans Phase 2 stroke and TBI study after successful DMT single dose study
Algernon NeuroScience testing psychedelic DMT to treat Stroke
Algernon Pharmaceuticals (AGN) CEO Chris Moreau Outlines DMT Stroke Research and Ifendprodil Plans
Algernon
Argonne's Exemplary Student Research Program
Algernon Pharmaceuticals Phase 1 DMT stroke study will start in September of 2022
Algernon Pharmaceutical’s preclinical study of DMT for stroke confirms growth of Neurons by 40%

Related Seekers

Algernon launching research program for treatment of stroke using Psychedelic drug DMT Algernon Pharmaceuticals launches new chronic kidney disease research program using Repirinast Algernon Pharmaceutical’s DMT Clinical Research Program for Stroke receives positive FDA feedback Algernon Pharmaceuticals provides update on chronic kidney disease research program with NP-251 Algernon Pharmaceuticals Stroke/DMT Clinical Program Algernon Pharmaceuticals plans Phase 2 stroke and TBI study after successful DMT single dose study Algernon NeuroScience testing psychedelic DMT to treat Stroke Algernon Pharmaceuticals (AGN) CEO Chris Moreau Outlines DMT Stroke Research and Ifendprodil Plans How Do Your Favorite Celebrities Make Such Astonishing Annual Earnings Revealed. Revealing The Jaw-Dropping Wealth Of Top-Tier Celebrities And Business Moguls. From Singers To Actors, Here's A Look At Celebrity Salaries Revealed The Surprising Truths Behind Celebrities' Multimillion-Dollar Bank Accounts. What's The Net Worth Of The Richest Rappers In The World? Uncovering The Fascinating Real-Life Stories Behind Hollywood's Biggest Stars. Uncovering The Surprising Truth About Rappers' Net Worth And Lifestyle Top 10 Richest Celebrities Of The World Unveiled
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored